Is treatment with ritonavir a risk factor for myocardial infarction in HIV-infected patients?

被引：28
|
作者：
Eriksson, U [1 ]
Opravil, M [1 ]
Amann, FW [1 ]
Schaffner, A [1 ]
机构：
[1] Univ Zurich Hosp, Dept Internal Med, CH-8091 Zurich, Switzerland
来源：
AIDS | 1998年 / 12卷 / 15期
关键词：
D O I：
10.1097/00002030-199815000-00024
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：2079 / 2080
页数：2
相关论文
共 50 条
  • [21] Population Pharmacokinetics of Lopinavir/Ritonavir (Kaletra) in HIV-Infected Patients
    Lopez Aspiroz, Elena
    Santos Buelga, Dolores
    Cabrera Figueroa, Salvador
    Lopez Galera, Rosa Maria
    Ribera Pascuet, Esteban
    Dominguez-Gil Hurle, Alfonso
    Garcia Sanchez, Maria Jose
    THERAPEUTIC DRUG MONITORING, 2011, 33 (05) : 573 - 582
  • [22] Ritonavir pharmacokinetics alone and in combination with saquinavir in HIV-infected patients
    Merry, C
    Barry, MG
    Mulcahy, F
    Tjia, JF
    Halifax, KL
    Heavey, J
    Kelly, C
    Back, DJ
    AIDS, 1998, 12 (03) : 325 - 327
  • [23] Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men
    Mary-Krause, M
    Cotteb, L
    Simon, A
    Partisani, M
    Costagliola, D
    AIDS, 2003, 17 (17) : 2479 - 2486
  • [24] Is impaired kidney function an independent predictor of the risk of myocardial infarction in HIV-infected individuals?
    Lang, Sylvie
    Mary-Krause, Murielle
    Partisani, Marialuisa
    Gilquin, Jacques
    Simon, Anne
    Cotte, Laurent
    Boccara, Franck
    Costagliola, Dominique
    AIDS, 2014, 28 (13) : 1987 - 1989
  • [25] Risk of acute myocardial infarction predicted by RAMA-EGAT score among HIV-infected Thai patients
    Suppadungsuk, S.
    Yamwong, S.
    Sungkanuparph, S.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2012, 16 : E192 - E192
  • [26] A pharmacogenetic study in HIV-infected patients treated with ritonavir: hematological and cardiovascular disease risk analysis
    Cusato, Jessica
    Calcagno, Andrea
    Antonucci, Miriam
    Marinaro, Letizia
    Avataneo, Valeria
    De Nicolo, Amedeo
    Bonora, Stefano
    Di Perri, Giovanni
    D'avolio, Antonio
    MINERVA BIOTECHNOLOGY AND BIOMOLECULAR RESEARCH, 2021, 33 (04): : 204 - 209
  • [27] Myocardial infarction in HIV-infected men receiving protease inhibitors
    Flynn, TE
    Bricker, LE
    ANNALS OF INTERNAL MEDICINE, 1999, 131 (07) : 548 - 548
  • [28] Comparison of two indinavir/ritonavir regimens in the treatment of HIV-infected individuals
    Acosta, EP
    Wu, HL
    Hammer, SM
    Yu, S
    Kuritzkes, DR
    Walawander, A
    Eron, JJ
    Fichtenbaum, CJ
    Pettinelli, C
    Neath, D
    Ferguson, E
    Saah, AJ
    Gerber, JG
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 37 (03) : 1358 - 1366
  • [29] Cardiovascular risk in HIV-infected patients
    Reis, Roberto Palma
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2019, 38 (07) : 471 - 472
  • [30] Hypertriglyceridaemia and small dense LDL-cholesterol in HIV-infected patients with myocardial infarction
    Mauss, S.
    Berger, F.
    Schmutz, G.
    Richter, W. O.
    ANTIVIRAL THERAPY, 2007, 12 (06) : L43 - L43
12345